SOURCE: National Institutes of Health (NIH)
APPLICATION DEADLINE: Letter of Intent: Due date is 30 days prior to the application due date. Application Due Date: June 22, 2021, Oct. 13, 2021, June 9, 2022, Oct. 11, 2022, June 9, 2023, and Oct. 10, 2023. All applications are due by 5 p.m. local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
$ AVAILABLE: NIH intends to fund an estimate of three to six awards, for fiscal year 2021. Future year amounts will depend on annual appropriations.
ELIGIBILITY:
• Public/state/private controlled institutions of higher education.
• Hispanic-serving institutions.
• Historically Black Colleges and Universities (HBCUs).
• Tribally Controlled Colleges and Universities (TCCUs).
• Alaska native and native Hawaiian serving institutions.
• Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
• Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
• Small businesses.
• For-profit organizations (other than small businesses).
• State governments.
• County governments.
• City or township governments.
• Special district governments.
• Indian/Native American tribal governments (federally recognized and other than federally recognized).
• Eligible agencies of the federal government.
• U.S. territories or possessions.
• Independent school districts.
• Public housing authorities/Indian housing authorities.
• Native American tribal organizations (other than federally recognized tribal governments).
• Faith-based or community-based organizations.
• Regional organizations.
• Non-domestic (non-U.S.) entities (foreign institutions).
PURPOSE: This funding opportunity announcement (FOA) is part of a suite of FOAs to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal of this FOA is to support team-based research projects to develop assays, screening and early optimization work to develop a non-addictive therapeutic to treat pain.
CFDA: 93.853, 93.213, 93.867, 93.866, 93.273, 93.846, 93.865, 93.121, 93.350, 93.242
CONTACT: Please see URL for multiple contacts. For more information, go to https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-015.html.
From Grants.gov website, accessed April 14, 2021.
Subject(s): medical research.